Dr. Glynn Wilson | Chief Executive Officer
Dr. Wilson previously served as a Director of TapImmune, Inc. from February 2005 until October 2018 and as Chief Executive Officer from July 2009 through September 2017 until its merger with Marker Therapeutics. Dr. Wilson also served as President of Auriga Laboratories, Inc. from June 1, 2005 through March 13, 2006, and as Chief Scientific Officer from March 13, 2016 through August 25, 2006. He was the Chief Scientific Officer at Tacora Corporation from 1994 to 1997 and was the Vice-President, R&D, at Access Pharmaceuticals from 1997 to 1998. Dr. Wilson was Research Area Head, Cell and Molecular Biology in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals from 1984-1989 and Worldwide Head of Drug Delivery at SmithKline Beecham from 1989 to 1994. He was an Assistant Professor at Rockefeller University, New York, in the laboratory of the Nobel Laureates, Sanford Moore and William Stein, from 1974 to 1979. Dr. Wilson was appointed as CEO due to his demonstrated success in leading public companies and approach to transforming scientific innovation into market-ready solutions. His ability to lead both scientific teams and corporate strategies ensures that the company can capitalize on its innovations and navigate complex regulatory and market environments, making him ideally suited to drive the company’s growth and operational success.
Brian John | Executive Chairman
For the past 20 years, Brian has been an investor and advisor to companies around the globe. He is the founder of Caro Partners, LLC, a financial consulting firm specializing in assisting emerging growth companies primarily in the sub- $100 million space and has worked with hundreds of companies in dozens of countries over the last 25 years. He also served on the board of directors of The Learning Center at the Els Center of Excellence–a school for children with autism in Jupiter, Florida from its opening until 2023. Mr. John founded and was CEO of Jupiter Wellness, now Safety Shot (NASDAQ: SHOT), He purchased SRM Entertainment in 2021 that now trades (NASDAQ: SRM) and was the CEO OF Jupiter Wellness Acquisition Corp NASDAQ: JWAC now CJET). Mr. John was appointed due to his proven track record in driving business growth, his entrepreneurial spirit, and his ability to navigate complex financial landscapes. His deep understanding of markets and his experience in successfully launching and managing publicly traded companies make him uniquely qualified to lead the company’s strategic initiatives.
Tyler Moore | Chief Financial Officer
Mr. Moore has over 20 years of experience in accounting and finance. Mr. Moore has a foundation in technical accounting and internal controls from his experiences at Ernst & Young and Deloitte in the assurance practice. From January 2018 to April 2021, Mr. Moore served as Chief Accounting Officer for Benefytt. During his time at Benefytt he was instrumental in completing three acquisitions, managing all public filings and audits, and taking the company private via a sale to private equity. From June 2021 to September 2023, Mr. Moore served in two roles, as Chief Accounting Officer and Chief Financial Officer with Health IQ. From October 2023 to June 2025, Mr. Moore served as SVP of Accounting for Waldencast, a multi-brand beauty and wellness company where he was responsible for managing financial operations, SEC compliance and reporting, financial statement audits, and other accounting and tax responsibilities. His deep knowledge of corporate finance, combined with his hands-on experience in financial controls and regulatory filings, positions him as a key figure in ensuring the company’s fiscal integrity and operational efficiency as it continues to grow.